Latest News

  • Finding Ovarian Cancer Before It’s Too Late: Researchers Fight Deadly Disease with Early Detection

    Diagnostics World | A group of researchers at the University of California Santa Cruz, University of Arizona, and University of Illinois at Chicago have identified a candidate biomarker that may help lead to earlier detection of ovarian cancer without the need for a biopsy. They hope that gynecologists could someday look for the presence of this biomarker while performing a routine Pap smear, but additional research involving more patients is still needed.

    Oct 18, 2023
  • Proteomics Enables Vastly Improved Cardiovascular Disease Prediction

    Diagnostics World | The rise and fall of blood protein levels over time is an astonishingly good way to assess the risk of major atherosclerotic cardiovascular disease (ASCVD) events such as myocardial infarction (heart attack), as well as an ideal biomarker of the progression of disease and its regression in response to treatment

    Oct 17, 2023
  • Illumina Ordered To Unwind Acquisition Of GRAIL

    Diagnostics World | The European Commission (EC), under the EU Merger Regulation (EUMR), released a statement last week announcing it has taken restorative measures that require Illumina to unwind its acquisition of GRAIL. The acquisition was completed before the EC provided approval, breaching EU merger control rules.

    Oct 16, 2023
  • Trends Driving Innovation in Blood Sample Collection, Preparation

    Diagnostics World | The laboratory side of diagnostic blood testing has achieved extraordinary efficiency and precision through automation. The last few decades of technology have allowed labs to simplify and automate sample processing to streamline operations and remove opportunities for human error.

    Oct 13, 2023
  • NCI To Conduct Massive Study To Evaluate Multi-Cancer Detection Assays

    Diagnostics World | The feasibility and design of a randomized controlled trial (RCT) for evaluating multi-cancer detection (MCD) assays suited to population-based cancer screening is the aim of a pilot Vanguard Study being undertaken by the National Cancer Institute (NCI).

    Oct 10, 2023
  • Children’s Mercy Brings Long Read Sequencing to Clinical Care

    Diagnostics World | Beginning today, the research team at Children’s Mercy Kansas City is bringing long read sequencing to clinical care, following three years of research and testing of PacBio HiFi sequencing. The transition is expected to speed the diagnostics odyssey for critically ill patients and their families.

    Oct 6, 2023